−£17k
vs Nov 2023Active08306757Private limited companyIlford
EK CLINICAL RESEARCH LTD
Significant control: Elias Khalifa (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Ek Clinical Research Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Ek Clinical Research Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
EK CLINICAL RESEARCH LTD is an active private limited company (company number 08306757) incorporated on 26 November 2012, registered in Ilford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 November 2024, showing net assets of −£17k and cash of £259, with 1 employee on average. Net assets rose 2% on the prior period (−£17k).
Peer position · net assets
By net assets it sits in the bottom quarter of 151 comparable companies in Greater London (median £200, upper quartile £53k).
02
Ownership and control
- Mr Elias Khalifa
- owns 75–100% of shares
- Dr Diyas Tri Wahyuni
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 26 November 201213 yrs ago
- Next accounts due
- 30 August 202656 days overdue
- Confirmation statement due
- 10 December 2026in 46 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£259
+250%vs Nov 2023Not reported
1
No changevs Nov 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2024 | −£17k | £259 | £1,265 | — | — | — | 1 |
| 30 November 2023 | −£17k | £74 | £1,265 | — | — | — | 1 |
| 30 November 2022 | — | — | — | — | — | — | — |
Cash per employee£259Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-16,862 at 30 November 2024
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 26 November 2012
- Accounts past their due dateDue 30 August 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 46 days
- Next accounts due56 days overdue
- Accounts period endNet liabilities £17k · small accounts
- Accounts period endNet liabilities £17k · small accounts
- Accounts period end
- Incorporated
08
Similar companies in Greater London
- POLYMATH INTERSCIENCE LIMITEDChafford Hundred · inc. Nov 2012
- BRITMOL LTDKent · inc. Dec 2012
- QUETHERA LIMITEDAddlestone · inc. Mar 2013
- CYTOCHROME LTDIlford · inc. May 2013
- PSIMONIX LTDHarrow · inc. May 2013
- ACE LABORATORIES LIMITEDUxbridge · inc. Jun 2013
All companies incorporated on 26 November 2012 · in Nov 2012.
09
Reminders for EK CLINICAL RESEARCH LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.